Prognostic parameters for flare in systemic lupus erythematosus

被引:93
作者
Mirzayan, MJ [1 ]
Schmidt, RE [1 ]
Witte, T [1 ]
机构
[1] Med Hsch Hannover, Abt Klin Immunol, D-30625 Hannover, Germany
关键词
SLE; flares; SLEDAI; prognosis;
D O I
10.1093/rheumatology/39.12.1316
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To characterize prognostic parameters for systemic lupus erythematosus (SLE) flares. Methods. In a prospective study, 120 SLE patients attending our out-patient clinic were evaluated every 3 months for 2 yr. At every visit clinical manifestations and laboratory parameters were assessed and the SLE disease activity index (SLEDAI) was determined. A correlation analysis of the number of flares in the first year and SLEDAI as a marker of disease activity after 1 and 2 yr with several parameters determined at the start of the study was performed. Results. Flares were predicted by erythrocyte sedimentation rate (P = 0.001), anaemia (P = 0.006) and lymphopenia (P = 0.005). The SLEDAI after 1 yr was predicted by the titre of antinuclear antibodies (P = 0.009), antibodies against double-stranded DNA (P = 0.007), lymphopenia (P = 0.007), anaemia (P = 0.0002) and SLEDAI determined at the start of the study (P = 0.001). Conclusions. Anaemia and lymphopenia predict both flares and SLEDAI within the next year of follow-up.
引用
收藏
页码:1316 / 1319
页数:4
相关论文
共 16 条
  • [1] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [2] Morbidity and mortality in systemic lupus erythematosus during a 5-year period -: A multicenter prospective study of 1,000 patients
    Cervera, R
    Khamashta, MA
    Font, J
    Sebastiani, GD
    Gil, A
    Lavilla, P
    Aydintug, AO
    Jedryka-Góral, A
    de Ramón, E
    Fernández-Nebro, A
    Galeazzi, M
    Haga, HJ
    Mathieu, A
    Houssiau, F
    Ruiz-Irastorza, G
    Ingelmo, M
    Hughes, GRV
    [J]. MEDICINE, 1999, 78 (03) : 167 - 175
  • [3] Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
    Hochberg, MC
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1725 - 1725
  • [4] HOCHBERG MC, 1990, RHEUM DIS CLIN N AM, V16, P617
  • [5] ANTI-DNA ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS - DIAGNOSTIC AND THERAPEUTIC GUIDE
    HUGHES, GRV
    COHEN, SA
    CHRISTIAN, CL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1971, 30 (03) : 259 - +
  • [6] A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value
    Jacobsen, S
    Petersen, J
    Ullman, S
    Junker, P
    Voss, A
    Rasmussen, JM
    Tarp, U
    Poulsen, LH
    Hansen, GV
    Skaarup, B
    Hansen, TM
    Podenphant, J
    Halberg, P
    [J]. CLINICAL RHEUMATOLOGY, 1998, 17 (06) : 478 - 484
  • [7] OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY OF PATIENTS FROM A DEFINED POPULATION
    JONSSON, H
    NIVED, O
    STURFELT, G
    [J]. MEDICINE, 1989, 68 (03) : 141 - 150
  • [8] LEBLANC BAEW, 1994, J RHEUMATOL, V21, P2239
  • [9] IMMUNE-COMPLEXES, COMPLEMENT, AND ANTI-DNA IN EXACERBATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    LLOYD, W
    SCHUR, PH
    [J]. MEDICINE, 1981, 60 (03) : 208 - 217